Quick Answer
TANDEM DIABETES CARE INC reported Gross Profit of $546.01 million for fiscal year 2025.
TANDEM DIABETES CARE INC Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $546.01M | +11.5% |
| 2024 | $489.57M | +33.1% |
| 2023 | $367.69M | -11.0% |
| 2022 | $412.99M | +9.8% |
| 2021 | $376.21M | +44.4% |
| 2020 | $260.52M | +34.1% |
| 2019 | $194.21M | +116.2% |
| 2018 | $89.82M | +103.7% |
| 2017 | $44.09M | +86.9% |
| 2016 | $23.59M | -11.2% |
| 2015 | $26.58M | +74.3% |
| 2014 | $15.25M | +147.3% |
| 2013 | $6.17M | +557.5% |
| 2012 | -$1.35M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $134.29M | +7.7% | +6.7% |
| June 30, 2025 | $125.86M | +11.6% | +6.3% |
| March 31, 2025 | $118.41M | +25.1% | -5.0% |
| September 30, 2024 | $124.65M | +38.9% | +10.5% |
| June 30, 2024 | $112.79M | +10.9% | +19.1% |
| March 31, 2024 | $94.67M | +14.2% | +5.5% |
| September 30, 2023 | $89.75M | -14.1% | -11.8% |
| June 30, 2023 | $101.73M | -0.2% | +22.7% |
- TANDEM DIABETES CARE INC showed an increase of +11.5% in Gross Profit compared to the prior fiscal year.
- Over the 2012–2025 period, TANDEM DIABETES CARE INC’s gross profit has grown by 40605.5% (from -$1.35 million to $546.01 million).
- The most recent figure is from TANDEM DIABETES CARE INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: